Description

Coming into being in the 1980s, penem is an unsatured B-lactam featuring broad spectrum, strong effect and low resistance rate. Actually it is the most potent antibiotic with the broadest antibacterial spectrum hitherto. And Imipenem cilastatin is one of the commercially available penem class.

Developed by Merck & Sharp Dohme (US) in 1979, imipenem and cilastatin sodium is the most famous one in imipenem cilastatin class. Its sales value around the world was USD 610 million in 2011 and USD 520 million in 2012, down 25.4% year-on-year. And imipenem and cilastatin sodium is used for the treatment of mixed infection caused by a variety of pathogens and aerobic or anaerobic bacteria as well as the early treatment before pathogens are identified.

View Full Report at: http://www.marketresearchreports.biz/analysis/294860

Imipenem and cilastatin sodium develops fast after entering China with annual sales value rising from less than CNY 200 million in 2005 to CNY 595 million in 2014 and CAGR during this period reaching 15.6%. Currently, imipenem and cilastatin sodium in the Chinese market mainly come from the following companies: Merck & Sharp Dohme (US), United Laboratories, RANBAXY LABORATORIES LTD(ID) and Shenzhen Haibin Pharmaceutical Co., Ltd, among which Merck & Sharp Dohme (US) has the largest market share of 90% for sales value in 2014.

As the development programs and manufacturers of penem antibiotics increase, the market competition will become more and more severe in future. The market size of imipenem and cilastatin sodium is expected to keep expanding in the next few years in China.

Download Detail Report With Complete TOC at: http://www.marketresearchreports.biz/sample/sample/294860

Readers can get at least the following information from this report:

market size of imipenem and cilastatin sodium in China
competitive landscape of imipenem and cilastatin sodium in Chinese market
price of imipenem and cilastatin sodium made by different enterprises in China
market outlook of imipenem and cilastatin sodium in China

The author suggests the following groups of people purchase this report:

manufacturers of anti-infective drugs
investors/ research institutions interested in Chinese medicine market
any interest in the Chinese medicine market, please contact CRI for customized survey service

Table Of Content

1 Related Concepts of Imipenem and cilastatin sodium
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Imipenem and cilastatin sodium in China
2.1 Patent and Approval Status of Imipenem and cilastatin sodium in China
2.2 Major Manufacturers
23 Market Size

3 Survey on Sales Status of Imipenem and cilastatin sodium in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions


Browse all latest Articles of Market Research Reports
at:http://www.marketresearchreports.biz/articles

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and money for our clients.
We are a one stop solution for all your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting services. We serve all sizes and types
of companies spanning across various industries.

Browse Our Press Releases by Prnewswire:
http://www.prnewswire.com/news/marketresearchreports.biz

Browse More PressRelease:
http://www.prweb.com/search.aspx?search-releases=marketresearchreports.biz

Contact
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA: Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: [email protected]